GMP-grade production of tIPE, a cell-based gene therapy product to treat neovascular age-related macular degeneration (nvAMD) developed in the TargetAMD project

Authors
Publication date
1 January 2018
Publisher
'Mary Ann Liebert Inc'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Publikationsserver der RWTH Aachen University

    redirect
    oaioai:publications.rwth-aachen.d...
    Last time updated on 18/04/2019